Investigation of Hepatitis C (HCV) Virus Epidemiology in the Capital City of Türkiye

Hepatitis C virus(HCV) infection represents a significant public health concern. In order to contribute to the epidemiological data, the present investigation aimed to examine in the prevalence of antibodies against the HCV, the rates of viremia, and the genotypes of HCV among patients in the capita...

Full description

Saved in:
Bibliographic Details
Main Author: Fatih Mehmet Akıllı
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716524004247
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850085872159948800
author Fatih Mehmet Akıllı
author_facet Fatih Mehmet Akıllı
author_sort Fatih Mehmet Akıllı
collection DOAJ
description Hepatitis C virus(HCV) infection represents a significant public health concern. In order to contribute to the epidemiological data, the present investigation aimed to examine in the prevalence of antibodies against the HCV, the rates of viremia, and the genotypes of HCV among patients in the capital city of Türkiye. This study was conducted between 1 January 2021 and 31 December 2023 in Sincan Training and Research Hospital. The anti-HCV tests Architect(Abbott, USA) and MAGLUMI(Snibe, China), besides HCV-RNA, were performed using Rotor-Gene Q(Qiagen, Germany). A total of 63226 patients' samples were tested for the presence of antibodies to HCV and for the presence of HCV RNA. HCV genotyping was performed on all viremic patients. In this study, the results were analysed retrospectively in conjunction with demographic data. HCV PCR(Polimerase chain reaction) positive patients were investigated HCV epidemiology. Of the 522 patients who were found to be anti HCV positive, 267 were patients admitted from prison. The study revealed that a prevalence of 0.8%(n:239) for anti-HCV positivity and a viremia prevalence(0.4%). HCV GT3(27.9%) was found to be the most common genotype, and following by GT1(26.2%), GT2(7%) and GT4(4.1%). The genotypes tested revealed that subtype 1b was present in 36.5% of GT1 patients and subtype 1a was present in 33.3%. HCV antibodies, viremia prevalence, viremia rate, genotype distribution are given in tables 1 and 2. We believe that our study will contribute to the elimination programs of HCV, which is an important public health problem, and to the epidemiological data in our region.
format Article
id doaj-art-528cd3dab3fd48a9bfda6013250b4d51
institution DOAJ
issn 2213-7165
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Journal of Global Antimicrobial Resistance
spelling doaj-art-528cd3dab3fd48a9bfda6013250b4d512025-08-20T02:43:38ZengElsevierJournal of Global Antimicrobial Resistance2213-71652024-12-01397610.1016/j.jgar.2024.10.247Investigation of Hepatitis C (HCV) Virus Epidemiology in the Capital City of TürkiyeFatih Mehmet Akıllı0Sincan Training and Research HospitalHepatitis C virus(HCV) infection represents a significant public health concern. In order to contribute to the epidemiological data, the present investigation aimed to examine in the prevalence of antibodies against the HCV, the rates of viremia, and the genotypes of HCV among patients in the capital city of Türkiye. This study was conducted between 1 January 2021 and 31 December 2023 in Sincan Training and Research Hospital. The anti-HCV tests Architect(Abbott, USA) and MAGLUMI(Snibe, China), besides HCV-RNA, were performed using Rotor-Gene Q(Qiagen, Germany). A total of 63226 patients' samples were tested for the presence of antibodies to HCV and for the presence of HCV RNA. HCV genotyping was performed on all viremic patients. In this study, the results were analysed retrospectively in conjunction with demographic data. HCV PCR(Polimerase chain reaction) positive patients were investigated HCV epidemiology. Of the 522 patients who were found to be anti HCV positive, 267 were patients admitted from prison. The study revealed that a prevalence of 0.8%(n:239) for anti-HCV positivity and a viremia prevalence(0.4%). HCV GT3(27.9%) was found to be the most common genotype, and following by GT1(26.2%), GT2(7%) and GT4(4.1%). The genotypes tested revealed that subtype 1b was present in 36.5% of GT1 patients and subtype 1a was present in 33.3%. HCV antibodies, viremia prevalence, viremia rate, genotype distribution are given in tables 1 and 2. We believe that our study will contribute to the elimination programs of HCV, which is an important public health problem, and to the epidemiological data in our region.http://www.sciencedirect.com/science/article/pii/S2213716524004247Hepatitis Canti-HCV antibodiesHCV genotypeepidemiology,Viremia
spellingShingle Fatih Mehmet Akıllı
Investigation of Hepatitis C (HCV) Virus Epidemiology in the Capital City of Türkiye
Journal of Global Antimicrobial Resistance
Hepatitis C
anti-HCV antibodies
HCV genotype
epidemiology,Viremia
title Investigation of Hepatitis C (HCV) Virus Epidemiology in the Capital City of Türkiye
title_full Investigation of Hepatitis C (HCV) Virus Epidemiology in the Capital City of Türkiye
title_fullStr Investigation of Hepatitis C (HCV) Virus Epidemiology in the Capital City of Türkiye
title_full_unstemmed Investigation of Hepatitis C (HCV) Virus Epidemiology in the Capital City of Türkiye
title_short Investigation of Hepatitis C (HCV) Virus Epidemiology in the Capital City of Türkiye
title_sort investigation of hepatitis c hcv virus epidemiology in the capital city of turkiye
topic Hepatitis C
anti-HCV antibodies
HCV genotype
epidemiology,Viremia
url http://www.sciencedirect.com/science/article/pii/S2213716524004247
work_keys_str_mv AT fatihmehmetakıllı investigationofhepatitischcvvirusepidemiologyinthecapitalcityofturkiye